Worta McCaskill-Stevens, M.D., M.S., has put in considerably of her job advancing investigation that supports women with breast most cancers, and the inclusion of underrepresented and underserved populations in clinical trials.
At the Countrywide Most cancers Institute (NCI), Dr. McCaskill-Stevens explores how race impacts cancer outcomes, especially in African American females, who are 40% far more very likely to die from breast most cancers than white women.
As element of her perform, Dr. McCaskill-Stevens can help oversee NCI breast most cancers studies all through the nation. Most not too long ago, she and her workforce at NCI served start a nationwide screening trial for breast most cancers people. They hope to far better recognize whether or not 3D mammography is improved at diagnosing highly developed breast cancers than the existing 2D technologies.
Why is this new screening demo so significant?
We have not had a screening trial for a long